ePoster presentation advances the preclinical evaluation of the importance of SERCA2a function to reduce arrythmias with istaroxime and a selective SERCA2a activator in the setting of ischemia and reperfusion ePoster presentation advances the preclinical evaluation of the importance of SERCA2a function to reduce arrythmias with istaroxime and a selective SERCA2a activator in the setting of ischemia and reperfusion

image for news Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025

ATLANTA, May 12, 2025 (GLOBE NEWSWIRE) -- nuVizz , a leading innovator in last-mile transportation management solutions (TMS), will present alongside Ford Motor Company at Home Delivery World 2025, one of North America's premier logistics and supply chain conferences. This session will provide a behind-the-scenes look at how nuVizz's specialized last-mile TMS is streamlining one of the most expensive aspects of Ford's logistics operations, creating a more innovative and efficient Dealer Delivery Service (DDS) network for parts deliveries.

image for news nuVizz and Ford Motor Company to Share Keys to 96% Parts Delivery Success at Home Delivery World

CPS Technologies to Participate in Sidoti Microcap Virtual Conference — Neutral

CPSH   GlobeNewsWire — May 12, 2025

NORTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced that, as it did last year, the Company will participate in the Sidoti Microcap Virtual Conference on May 21 and 22, 2025. A general presentation by management will be held at 9:15 a.m. Eastern on May 21, with one-on-one calls scheduled throughout the 21st and 22nd; institutional investors are encouraged to contact Sidoti directly or CPS investor relations with any questions or to confirm a time to speak with management. The general presentation will be webcast and will subsequently be made available …

image for news CPS Technologies to Participate in Sidoti Microcap Virtual Conference

eBay: A Potential AI Winner — Positive

EBAY   Seeking Alpha — May 12, 2025

eBay's AI tools streamline seller listings and enhance buyer searches, boosting efficiency and increasing inventory visibility, which can drive higher sales. EBAY's low capital expenditures and high free cash flow allow for share buybacks, dividend increases, and technology acquisitions, making it financially robust. The Company's valuation is attractive compared to Amazon, with a lower P/E ratio and significant share buybacks, suggesting it is undervalued.

image for news eBay: A Potential AI Winner

BOCA RATON, FL, May 12, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) announced today the purchase of 172,670 Solana (“SOL”) at an average purchase price of $136.81 and valued at approximately $23.6 million. This marks the Company's 10th Solana purchase under its digital asset treasury strategy and the largest purchase to date. Following the transaction, DeFi Development Corp. now holds a total of 595,988 SOL, valued at approximately $102.7 million, inclusive of staking rewards.

image for news DeFi Development Corp. Purchases Record 172,670 SOL, Surpasses $100M in Treasury Holdings

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission

image for news Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that dosing of drug has completed in 90-day oral toxicity and toxicokinetic studies for Lucid-21-302 (Lucid-MS) for Multiple Sclerosis (“MS”). These studies were commissioned to provide data to support an IND application with the US FDA.

image for news Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial, demonstrating proof-of-concept for neflamapimod as a potential treatment for dementia with Lewy bodies (DLB)

image for news CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates

WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN). As the biopharma industry faces increasing competition from international markets and an evolving regulatory landscape, Tevogen Bio's innovative business model positions it as a potential leader in the shift towards cost-efficient, value-driven healthcare.

image for news Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

Unlocking the potential of digital assets for institutions and fueling Amber International's strategic expansion SINGAPORE , May 12, 2025 /PRNewswire/ -- Amber International Holding Limited (Nasdaq: AMBR) ("Amber International", "AMBR", "we", "us", or the "Company"), a leading provider of institutional crypto financial services and operating under the brand name "Amber Premium", today announced the launch of its upsized crypto ecosystem reserve plan of US$100 million. The strategic treasury reserve initiative is designed to accelerate the Company's expansion and cement its leadership at the intersection of traditional and decentralized finance.

image for news Amber International Unveils US$100M Crypto Ecosystem Reserve to Expand Institutional Crypto Adoption

Arbe to Participate in Upcoming Investor Conferences — Neutral

ARBE   PRNewsWire — May 12, 2025

TEL AVIV, Israel , May 12, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that Kobi Marenko, Chief Executive Officer will participate in the following investor conferences: Ladenburg Innovation Expo Format: In-person presentation and meetings When: Wednesday, May 21, presentation at 2:00 pm ET Where: New York City 15th Annual Roth London Conference Format: In-person meetings When: Wednesday, June 25 Where: London, U.K. The Ladenburg Innovation Expo presentation will be webcast from Arbe's Investor Relations website: https://ir.arberobotics.com/news/ir-calendar.

image for news Arbe to Participate in Upcoming Investor Conferences

Innovative pilot project highlights the role of thermal energy storage in decarbonizing public institutions Pilot installations offer replicable frameworks for wider adoption Brenmiller's bGen™ intended to reduce 550 metric tons of CO2 emissions annually The project and its key findings will be presented in a webinar on May 19, 2025 hosted by the Renewable Thermal Collaborative TEL AVIV, IL / ACCESS Newswire / May 12, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of thermal energy storage ("TES") solutions for industrial and utility customers, announced today the publication of a joint case …

image for news Brenmiller Energy and New York Power Authority Showcase Thermal Energy Storage Success at SUNY Purchase College

~ Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it has added Tracy Hysong, CCRA as Senior Director of Regulatory Affairs to its management team. Ms. Hysong is a Certified Clinical Research Associate (CCRA) through the Association of Clinical Research Professionals with years of experience undertaking regulatory activity at the University of California Davis (UC Davis).

image for news Ensysce Biosciences Bolsters Management Team with Regulatory Expert

Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today addresses frequently asked stockholder questions regarding a reverse stock split proposal at the Company's Annual Meeting taking place on Wednesday, May 21, 2025, to regain Nasdaq compliance.

image for news Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement

LEXINGTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that Keros' Chair and Chief Executive Officer Jasbir S.

image for news Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference

Topline results for the Phase 2 Avail™ evaluating canvuparatide in patients with hypoparathyroidism expected in 3Q 2025 Investigational New Drug submission for MBX 4291 on track for 2Q 2025 $240.8 million in cash, cash equivalents and marketable securities as of March 31, 2025; expected to support operations into mid-2027 CARMEL, Ind., May 12, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today reported financial results for the first quarter ended March 31, 2025, and highlighted recent …

image for news MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Meat Snacks and Sweet & Salty Offerings Highlight Two Booths in Indianapolis CHICAGO , May 12, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG), one of North America's leading branded food companies, is preparing to showcase the company's dynamic range of snacks at the National Confectioners Association's 2025 Sweets & Snacks Expo in Indianapolis. Meat snacks, sweet treats, and salty snacks comprise the company's $3.2 billion 1 snacks portfolio, with numerous industry-leading brands headlining Conagra Brands' Expo presence.

image for news Conagra Brands Brings Diverse Collection of Snacks to 2025 Sweets & Snacks Expo

SHERIDAN, Wyo. , May 12, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) announced today it has hired Michael Woloschuk, an internationally recognized leader in the critical minerals industry, with over 30 years of project development experience in all parts of the world.

image for news Ramaco Hires Executive Vice President for Critical Mineral Operations to Lead the Brook Mine Rare Earth Element and Critical Minerals Project

NEW YORK , May 12, 2025 /PRNewswire/ -- Fox Corporation (Nasdaq: FOXA, FOX; "FOX" or the "Company") today reported financial results for the three months ended March 31, 2025. The Company reported total quarterly revenues of $4.37 billion, an increase of $924 million or 27% from the amount reported in the prior year quarter.

image for news FOX REPORTS THIRD QUARTER FISCAL 2025 REVENUES OF $4.37 BILLION, NET INCOME OF $354 MILLION, AND ADJUSTED EBITDA OF $856 MILLION

Jack Henry & Associates Announces Regular Quarterly Dividend — Neutral

JKHY   PRNewsWire — May 12, 2025

MONETT, Mo. , May 12, 2025 /PRNewswire/ -- Jack Henry & Associates, Inc. (NASDAQ: JKHY) today announced its Board of Directors declared a regular quarterly cash dividend of $.58 per share.

image for news Jack Henry & Associates Announces Regular Quarterly Dividend